Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples



► Subscribe to EMAT database


Sectors covered by our analysts


► Studies & indices published by Epsilon Research: Register to receive (free) publications updates


► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Transaction Multiples for the Valuation of Private Companies

Funding round led by Advent France Biotechnology / Wellium (Feelae)

No EMAT : 103637
Announced Date : 10/02/2020
Type : Acquisition of Minority Stake
Deal Value : Yes
Acquirer : Funding round led by Advent France Biotechnology

Target : Wellium (Feelae)
Country : Puy-De-Dôme
Sector of activity :
  • Specialized Software > Business Software > Software > Medical Software
  • Internet > e-services (B2C)
Business Description :
Founded in 2016 by Alban de Crémiers and Benjamin Bouzerau Lévy, Wellium is a telemedicine company. > Offers two teleconsultation solutions : Leah (launched in 2019): online consultation and video...

Transaction multiples available
Gross Profit
P/E Price
to Book
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Software » = 67
  • Number of EMAT Reports / sub-sector « e-services (B2C) » = 45
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
27/03/2019 Private Group led by China Synergy Fund Electropoli Manche ** 104248
30/09/2004 NWD Group Plc Clinic Group Ltd United Kingdom ** 10235

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report